Related Experiment Video
Updated: Aug 11, 2025
10:56
Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
Published on: July 23, 2014
19.0K
Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol
Taufiek Konrad Rajab1, Brielle Ochoa1, Kasparas Zilinskas2
1Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Plos One
|February 7, 2023
Summary
Partial heart transplantation offers a novel solution for infants with congenital heart defects. This innovative approach aims to provide a growing, living valve replacement, addressing limitations of current treatments in young children.
Area of Science:
- Pediatric cardiology
- Congenital heart disease research
- Transplant surgery innovation
Background:
- Congenital heart defects are common, often causing heart valve dysfunction.
- Current treatments like implants or transplants are suboptimal for infants and young children.
- There's a critical need for growing valve replacements in pediatric patients.
Purpose of the Study:
- To introduce and evaluate a novel
- partial heart transplantation
- procedure for infants with irreparable heart valves.
- To address the limitations of existing treatments in pediatric congenital heart disease.
Main Methods:
- A single-arm, prospective study protocol is described.
- Partial heart transplantation involves transplanting only the valve-containing heart section.
- Requires immunosuppression, similar to conventional heart transplants.
Main Results:
- Partial heart transplants are designed to grow with the child.
- Immunosuppression risks are manageable, akin to orthotopic heart transplant recipients.
- The procedure offers a potential long-term solution, with options for future mechanical implants.
Conclusions:
- Partial heart transplantation presents a promising alternative for treating irreparable heart valves in infants.
- This technique aims to overcome the growth limitations of current pediatric cardiac interventions.
- Further clinical evaluation is underway (NCT05372757).
